Evidence map›Paper›PMID 38453249›Full record

ArticleBMJ global health2024

Maternal and perinatal health research during emerging and ongoing epidemic threats: a landscape analysis and expert consultation.

Mercedes Bonet, Magdalena Babinska, Pierre Buekens, Shivaprasad S Goudar, Beate Kampmann, Marian Knight, Dana Meaney-Delman, Smaragda Lamprianou, Flor Muñoz Rivas, Andy Stergachis and 10 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 6 countries.

Mercedes BonetUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland bonetm@who.int.ORCID http://orcid.org/0000-0001-9015-1635
Magdalena BabinskaUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0009-0008-7850-4168
Pierre BuekensDepartment of Epidemiology, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.ORCID http://orcid.org/0000-0002-4294-8559
Shivaprasad S GoudarWomen's and Children's Health Research Unit, KLE Academy of Higher Education and Research's, Jawaharlal Nehru Medical College, Belgaum, Karnataka, India.ORCID http://orcid.org/0000-0002-8680-7053
Beate KampmannCharité Centre for Global Health, Universitätsmedizin Charité Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-6546-4709
Marian KnightNational Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-1984-4575
Dana Meaney-DelmanDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Smaragda LamprianouPharmacovigilance Team, Regulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization, Geneva, Switzerland.
Flor Muñoz RivasDepartments of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine, and Texas Children's Hospital, Houston, Texas, USA.ORCID http://orcid.org/0000-0002-0457-7689
Andy StergachisSchool of Pharmacy and School of Public Health, University of Washington, Seattle, Washington, USA.
Cristiana M ToscanoInstitute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, Brazil.
Joycelyn BhatiaBoston Consulting Group, London, UK.
Sarah ChamberlainBoston Consulting Group, London, UK.
Usman ChaudhryBoston Consulting Group, London, UK.
Jacqueline MillsBoston Consulting Group, London, UK.
Emily SerazinBoston Consulting Group, London, UK.
Hannah ShortBoston Consulting Group, London, UK.
Asher SteeneBoston Consulting Group, London, UK.
Michael WahlenBoston Consulting Group, London, UK.
Olufemi T OladapoUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-3371-5892
PA Consulting Group · GBWorld Health Organization · CHBaylor College of Medicine · USCenters for Disease Control and Prevention · USCharité - Universitätsmedizin Berlin · DEJawaharlal Nehru Medical College · INTulane University · USUniversidade Federal de Goiás · BRUniversity of Oxford · GBUniversity of Washington · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionPregnant women and their offspring are often at increased direct and indirect risks of adverse outcomes during epidemics and pandemics. A coordinated research response is paramount to ensure that this group is offered at least the same level of disease prevention, diagnosis, and care as the general population. We conducted a landscape analysis and held expert consultations to identify research efforts relevant to pregnant women affected by disease outbreaks, highlight gaps and challenges, and propose solutions to addressing them in a coordinated manner.

methodsLiterature searches were conducted from 1 January 2015 to 22 March 2022 using Web of Science, Google Scholar and PubMed augmented by key informant interviews. Findings were reviewed and Quid analysis was performed to identify clusters and connectors across research networks followed by two expert consultations. These formed the basis for the development of an operational framework for maternal and perinatal research during epidemics.

resultsNinety-four relevant research efforts were identified. Although well suited to generating epidemiological data, the entire infrastructure to support a robust research response remains insufficient, particularly for use of medical products in pregnancy. Limitations in global governance, coordination, funding and data-gathering systems have slowed down research responses.

conclusionLeveraging current research efforts while engaging multinational and regional networks may be the most effective way to scale up maternal and perinatal research preparedness and response. The findings of this landscape analysis and proposed operational framework will pave the way for developing a roadmap to guide coordination efforts, facilitate collaboration and ultimately promote rapid access to countermeasures and clinical care for pregnant women and their offspring in future epidemics.

Indexed as

Delivery of Health CarePandemicsDisease OutbreaksFemaleHumansPregnancyEpidemiologyInfections, diseases, disorders, injuriesMaternal healthObstetricsReview

Identifiers

PMID38453249
PMCPMC10921500
OpenAlexW4392553499

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.